Three-dimensional ultrasound-based radiomics nomogram for the prediction of extrathyroidal extension features in papillary thyroid cancer
Frontiers in Oncology · 23.08.2023 · 13
DOI: 10.3389/fonc.2023.1046951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 23.08.2023. Verfasst von Wen-Jie Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To develop and validate a three-dimensional ultrasound (3D US) radiomics nomogram for the preoperative prediction of extrathyroidal extension (ETE) in papillary thyroid cancer (PTC).
Methods
This retrospective study included 168 patients with surgically proven PTC (non-ETE, n = 90; ETE, n = 78) who were divided into training (n = 117) and validation (n = 51) cohorts by a random stratified sampling strategy. The regions of interest (ROIs) were obtained manually from 3D US images. A larger number of radiomic features were automatically extracted. Finally, a nomogram was built, incorporating the radiomics scores and selected clinical predictors. Receiver operating characteristic (ROC) curves were performed to validate the capability of the nomogram on both the training and validation sets. The nomogram models were compared with conventional US models. The DeLong test was adopted to compare different ROC curves.
Results
The area under the receiver operating characteristic curve (AUC) of the radiologist was 0.67 [95% confidence interval (CI), 0.580–0.757] in the training cohort and 0.62 (95% CI, 0.467–0.746) in the validation cohort. Sixteen features from 3D US images were used to build the radiomics signature. The radiomics nomogram, which incorporated the radiomics signature, tumor location, and tumor size showed good calibration and discrimination in the training cohort (AUC, 0.810; 95% CI, 0.727–0.876) and the validation cohort (AUC, 0.798; 95% CI, 0.662–0.897). The result suggested that the diagnostic efficiency of the 3D US-based radiomics nomogram was better than that of the radiologist and it had a favorable discriminate performance with a higher AUC (DeLong test: p < 0.05).
Conclusions
The 3D US-based radiomics signature nomogram, a noninvasive preoperative prediction method that incorporates tumor location and tumor size, presented more advantages over radiologist-reported ETE statuses for PTC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zitieren
APA
Lu, W. J., Mao, L., Li, J., OuYang, L. Y., Chen, J. Y., Chen, S. Y., Lin, Y. Y., Wu, Y. W., Chen, S. N., Qiu, S. D., & Chen, F. (2023). Three-dimensional ultrasound-based radiomics nomogram for the prediction of extrathyroidal extension features in papillary thyroid cancer. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1046951
Vancouver
Lu WJ, Mao L, Li J, OuYang LY, Chen JY, Chen SY, et al. Three-dimensional ultrasound-based radiomics nomogram for the prediction of extrathyroidal extension features in papillary thyroid cancer. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1046951
BibTeX
@article{Lu2023,
author = {Lu, Wen-Jie and Mao, Lin and Li, Jin and OuYang, Liang-Yan and Chen, Jia-Yao and Chen, Shi-Yan and Lin, Yun-Yong and Wu, Yi-Wen and Chen, Shao-Na and Qiu, Shao-Dong and Chen, Fei},
title = {Three-dimensional ultrasound-based radiomics nomogram for the prediction of extrathyroidal extension features in papillary thyroid cancer},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1046951}
}
EUVIMED